2m 2m 2m 2m 2m 2m 2m
CEN Biotech (CENBF)
OTC
$0.0001$0.00 (0.00%)
Price as of May 27, 2026- $6,525.00Market Cap
- 9,900.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CEN Biotech (CENBF)
$0.0001$0.00 (0.00%)
CENBF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 7,272 | ||
30-Day Average Volume | 1,895 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.00% | ||
1-Year Change | 9,900.00% | ||
3-Year Change | -99.54% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 65.3M | ||
Total Assets | $7.9M | ||
Market Cap | $6,525.00 | ||
Enterprise Value | $5.0M | ||
Period: QTR TTM FY | |||
Revenue | $135,856.00 | ||
Net Income | -$400,227.00 | ||
Free Cash Flow | -$90,146.00 | ||
EBIT | -$385,092.00 | ||
EBITDA | -$192,926.00 | ||
Net Working Capital | -$9.5M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | 37 | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||